Overview
- CustomCells permanently closed its Tübingen plant, with all 68 employees facing termination by the end of July.
- The company filed for insolvency in May after the aviation startup Lilium failed to pay for delivered battery cells.
- A family-office consortium led by ABACON with support from SALVIA acquired CustomCells’ core business under insolvency protection.
- The shutdown underscores challenges for European battery startups relying on heavy R&D subsidies and a small number of strategic customers.
- Insolvency administrator Dr. Malte Köster affirmed that the rescued business has stable prospects even as the state-funded Tübingen pilot plant plans are abandoned.